Print this page
Novel Immune Checkpoint Expression on Circulating Tumor Cells of Sarcomas.
Objectives:
- To describe the expression pattern and clinical significance of novel B7 family immune checkpoints on circulating tumor cells from patients with pediatric sarcomas.
- To describe the clinical significance, including trends relating to relapse, of these novel immune checkpoints on circulating tumor cells from patients with pediatric sarcomas
Protocol Number:
112103
Phase:
N/A
Applicable Disease Sites:
Soft Tissue
Principal Investigator:
Scott Moerdler M.D.
Scope:
Local
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
For further information about clinical trials, please contact us at 732-235-7356.